The characteristic changes of GLP-1 face include 4,5 : Facial volume loss, particularly in the midface Periocular hollowing and periorbital volume depletion Dermal thinning with loss of collagen and elastin fibers Decreased skin elasticity leading to redundant skin folds Accelerated appearance of aging As a result of these facial changes, GLP-1 agonist medications can result in an older, haggard and tired looking appearance
Will more patients receive the benefit
Glucagon-like peptide 1: a potent glycogenic hormone
These foods not only help in maintaining muscle mass but also aid in regulating appetite and glucose metabolism, indirectly supporting GLP-1 function
While preclinical studies vary, most researchers start with a low dosage to observe peptide stability and initial biological responses
Others are readily fermented by the microbiome and produce compounds that are beneficial to immunity, glycaemic control and appetite